Accordingly, upon MCT1 inhibition we observed that oxidative cancer cells switched substrate from lactate to glucose and survived, which indirectly killed hypoxic cancer cells through glucose starvation in experimental tumors [13]. The gene discussed is SLC16A1; the disease is cancer.